P1-036: Characteristics of non-small cell lung cancer in patients under 40: a National Cancer Database (NCDB) Analysis 1998-2004  by Velcheti, Vamsidhar et al.
Copyright © 2007 by the International Association for the Study of Lung Cancer S563
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
Result: There were total of 339 patients: 158 females and 181 males. 
33 of 107 (30.8%) patients with stage IIIB had documented malignant 
PE, while 31 of 232 (13.4%) patients with stage IV had malignant PE 
(p=<0.01). The median survivals for the 4 subgroups of patients: stage 
IIIB without PE, IIIB with PE, IV without PE and IV with PE were 27 
mo, 6 mo, 10 mo and 7 mo respectively. The survival for stage IIIB 
without PE was statistically signiﬁcantly different from the other three 
subgroups (p=<0.0001). Median survival was 10 months for females 
and 7 months for males (p=0.001).
In univariate analysis, age, histology, family history, menopausal status, 
ethnicity, and smoking history were not signiﬁcant independent prog-
nostic factors. 
There were no signiﬁcant relationships between stage and age, gender, 
or histology. Similarly, there were no associations between family his-
tory and age at diagnosis or histology. 
Conclusion: Malignant PE is more commonly seen with IIIB than IV 
NSCLC, and is an independent prognostic discriminant for survival. 
Survivals of patients with PE in both IIIB and IV are similar, and a 
non-signiﬁcant trend suggests a worse prognosis in comparison to pa-
tients with IV without PE. The small sample size may have contributed 
to the lack of statistically signiﬁcant result. Patients with NSCLC and 
malignant PE could be categorized separately in the staging system if 
these results are statistically conﬁrmed by future studies.
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Distinctive characteristics of non-small cell lung cancer (NSCLC) 
in the young: Washington University experience
Subramanian, Janakiraman; Velcheti, Vamsidhar; Goodgame, Boone; 
Gao, Feng; Baggstrom, Maria; Govindan, Ramaswamy 
St. Louis, MO, USA
Background: NSCLC predominantly affects patients in their sixth 
and seventh decades of life. It is unclear whether the presentation and 
outcomes are different in the younger (deﬁned as age ≤ 40 years at the 
time of diagnosis) when compared with older patients (age > 40).
Methods: We reviewed the demographic, clinical and pathologic data 
of all patients diagnosed with NSCLC at Washington University School 
of Medicine-Siteman Cancer Center from 1990 to 2005.
Results: 6118 patients with NSCLC were identiﬁed and among them 
6010 were > 40 years and 108 were ≤ 40 years of age at the time of 
diagnosis. The proportion of women in the younger group was 53.7% 
vs. 43.6% in the older group (p = 0.03). The distribution of stages I, 
II, III and IV in the younger group was 14%, 7.5%, 34.6% and 43.9% 
as compared to 28.9%, 7.8%, 29.8% & 33.5% in the older group (p = 
0.006). Adenocarcinoma was the most common histology in the young-
er group compared to the older group (53.7% vs. 38.1%, p<0.001). 
Squamous cell carcinoma was less common in the younger vs. older 
group (15.7% vs. 29.9%, p<0.001). The proportion of younger patients 
diagnosed with brain metastasis at presentation was 18.5% vs. 10% in 
the older patients (p = 0.004). No signiﬁcant differences were detected 
for metastases to the other sites. The 5-year survival was higher in the 
younger group for each stage, but reached statistical signiﬁcance only 
in stage I disease, likely because of the small sample size (see table).
Conclusion: Lung cancer in younger patients is characterized by 
higher proportion of women, adenocarcinoma histology, stage IV dis-
ease, brain metastases at presentation and better overall survival when 
compared to older patients.
Table. Stage speciﬁc 5-year survival
 Age ≤ 40 Age ≤ 40 Age > 40 Age > 40 p value
 N
5 yr survival 
(%)
N
5 yr survival 
(%)
 
Stage I 15 85 1698 45 0.01
Stage II 8 64 469 31 0.20
Stage III 37 20 1789 12 0.13
Stage IV 47 9 2019 2 0.052
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Characteristics of non-small cell lung cancer in patients under 40: 
a National Cancer Database (NCDB) Analysis 1998-2004
Velcheti, Vamsidhar; Chitneni, Pooja; Goodgame, Boone; 
Morgensztern, Daniel; Gao, Feng; Baggstrom, Maria; Govindan, 
Ramaswamy 
Washington University, St Louis, MO, USA
Background: The median age of patients presenting with non-small 
cell lung cancer (NSCLC) is 70 years and the condition is rare in 
younger adults. NSCLC appears to have a different presentation and 
natural history in younger patients. 
Methods: The National Cancer Data Base (NCDB) is a cancer data-
base maintained by the American College of Surgeons. The NCDB data 
is obtained from the cancer programs participating in the Commission 
on Cancer NCDB annual call for data. Permission was obtained from 
the American College of Surgeons to access and analyze the data for 
publication. All patients diagnosed with NSCLC from 1998 to 2004 
were identiﬁed from the NCDB. The gender, race, stage and histology 
data were obtained from the NCDB. The characteristics of patients with 
NSCLC from 16-39 years of age were compared to the entire group. 
Results: A total of 657,982 patients with NSCLC were diagnosed from 
1998-2004. Only about 0.7% (4769) of these patients was under 40. We 
compared the characteristics of NSCLC in younger group to the entire 
cohort (Table). Younger patients were more likely to be women, 52 
% vs 42 % (p<0.001), and more likely to present with distant disease 
(stage 3 & 4) 74 % vs 60 % (p<0.001). Adenocarcinoma was more 
common in younger patients, 46 % vs. 37 %. Squamous cell carcinoma 
was far less common in younger patients, 12 % vs 27 % (p<0.001). 
Conclusions: Patients with NSCLC who are < 40 years old at diagno-
sis are more likely to be women and have adenocarcinoma and far less 
likely to have squamous cell carcinoma. Thus it appears that NSCLC in 
patients <40 years are biologically different.
<40  % All Patients %
Total Number 4769  657982  
Gender 
 Male 2287 48.0 380645 57.9
 Female 2482 52.0 277337 42.1
Race 
 White 3502 73.4 554147 84.2
 Black 715 15.0 68427 10.4
 Asian 194 4.1 10652 1.6
 Other 358 7.5 24756 3.8
Stage 
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 I 589 12.4 157815 24.0
 II 303 6.4 51253 7.8
 III 1190 25.0 169325 25.7
 IV 2345 49.2 229240 34.8
 unknown 342 7.0 50349 7.7
Histology 
 Adenocarcinoma 2208 46.3 246950 37.5
 Squamous 557 11.7 179428 27.3
 Large Cell 443 9.3 45796 7.0
 BAC 156 3.3 23836 3.6
 NSCLC 578 12.1 93666 14.2
 Other 827 17.3 68306 10.4
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Epidemiological study of lung cancer in western Mexico
Gurrola-Diaz, Carmen M.1 Gonzalez-Santiago, Ana E.1 Gonzalez-
Valencia, Jessica1 Santillan-Loza, Paola G.1 Plascencia-Ortiz, Teresita2 
Mendoza-Topete, Luz A.2 Troyo-Sanroman, Rogelio1 
1 Universidad de Guadalajara, Guadalajara, Mexico 2 Instituto Mexi-
cano del Seguro Social, Guadalajara, Mexico 
Objective: The aims of this study were to describe histological and 
clinical characteristics of lung cancer patients and its impact on diag-
nosis in the western region of Mexico over a period of four years and 
compare them with those historical series of other regions of Mexico 
and other countries.
Patients and methods: We studied retrospectively 1312 cases with 
clinical diagnosis of lung cancer, from the Department of pulmonary 
physiology (Western National Medical Center), from January 2002 to 
December 2005. Statistic analysis: Gender and age was compared with 
x2 test. Differences between diagnostic methods were established using 
comparative contingency tables. P value less than 0.05 was considered 
statistically signiﬁcant.
Results: Accordingly gender, 57% of lung cancer patients were men 
and 43% women. The average age was 51 years old. 14.3% had a 
deﬁnitive diagnosis of lung cancer. The average of analyzed samples 
for each patient was 1.67; nevertheless, there was cases with until 
8 samples. The average of patients with deﬁnitive diagnosis of lung 
cancer per year was 46.5 from 323. The most common histological 
type of lung cancer was adenocarcinoma (65%), followed by squamous 
cell lung cancer (20%). The most frequent diagnostic methods were: 
bronchial aspirate, pleural cytology and bronchial biopsy. Our study 
reveals statistical differences on frequency of lung cancer histological 
types compared with reports from Finland, Poland, Turkey, Spain and 
United States of America. Otherwise, the comparison between studies 
from other regions of our country and these results present similar 
frequencies.
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Overview of lung cancer in Dharmais National Cancer Hospital, 
Jakarta, Indonesia
Harsal, Asrul; Suratman, Eddy; Tambunan, Tagor 
Dharmais National Cancer Hospital, Jakarta, Indonesia
Background: Lung cancer is the ﬁrst cause of death in cancer patient, 
and Lung cancer mostly diagnosed at late stage, and survival was poor. 
To know the characteristic of lung cancer in our institution, we evalu-
ated lung cancer patient about, gender ratio, mean age, stage, type of 
cytology, distant metastatic, treatment and others.
Methods: From January 2004 to December 2004, we collected and 
analyzed the data ﬁles of lung cancer patient. This is the retrospective 
study, some data not completely.
Results: From total of 67 patients, 51 pts are man and 16 pts are 
woman, and average age 57 years old. The type of cancer are; SCLC 4 
% and NSCLC 96 %.
All SCLC are extensive stage, with brain metastatic, and NSCLC, stage 
IIIA; 2 %, IIIB; 46% and stage IV:52%.From the available data, cytol-
ogy ﬁndings are; Adenocarcinoma: 54 %, Squamous Cell Ca:22 %, 
Large cell Ca:4 %, and no describe the type of cytology: 20 %. Distant 
metastatic are bones: 19 pts, brain; 6 pts, liver; 5 pts, and contra lateral 
of lung: 5 pts. Chemotherapy was given to 23 pts (34 %), chemoradia-
tion for 2 pts (3%), and palliative radiotherapy for brain metastatic 
and bones;19 pts (28 %). Combination of chemotherapy was platinum 
based ( cisplatin or carboplatin) combined with etoposide, paclitaxel, 
gemcitabine, docetaxel, and irinotecan ) as ﬁrst or second line chemo-
therapy, one patients got Geﬁtinib after chemotherapy. 
Conclusion: Mostly diagnosis of lung cancer stage IIIB and IV. The 
type of cytology; Adenocarconoma is predominant, the four sites for 
metastatic are bones, liver, brain and lung, chemotherapy and target 
therapy was given for 34 % of patient.
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Multiple carcinomas in the lung cancer patients
Jancarikova, Dana; Pesek, Milos 
Faculty of Medicine in Pilsen, Dept. of Tuberculosis and Resp. Dis-
eases, Pilsen, Czech Republic
Background: We have observed increasing rate of patients suffer-
ing from multiple primary carcinomas over the last ten years.The aim 
of this study was to ﬁnd signiﬁcant frequencies of various malignant 
tumour associations, as well as common risk factors, evaluation of 
therapy, prognosis and survival of patients with conﬁrmed lung cancer 
and additional primary malignancies.
Patients and Methods: This metastudy included 142 patients suffering 
from more than one primary carcinoma (synchronous or metachro-
nous appearance), where one of the tumours was histopathologically 
conﬁrmed lung cancer. Patients were registered in our department 
between 1995 and the fall of 2006. We have analysed their gender, age, 
family history, smoking status, date of the ﬁrst malignancy, as well as 
the timing of the secondary (or tertiary) malignancies. In addition we 
have observed the most frequent mutual associations of the tumours, 
outcome of therapy, survival rates, etc.
Results: There were 118 men and 24 women, age ranging from 26 to 
79 years. The longest interval between each carcinoma diagnoses was 
29 years (larynx and lung cancer) and 26 years (malignant lymphoma 
and lung cancer). The shortest interval corresponded to a simultaneous 
occurrence of lung cancer duplicity with different morphology. Median 
time interval between malignant tumours was 3 years.
Discussion: In our group predominance of men (83%) is evident, 
which could be explained by pre-selection of lung carcinoma be-
ing more common in men. 84% of patients were smokers (current or 
